Significant Ownership of John R. Murphy

Location
Springfield, MO
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by John R. Murphy.

Notify me when John R. Murphy files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of John R. Murphy

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CVKD Cadrenal Therapeutics, Inc. Common Stock, $0.001 par value per share 3% $798,075 53,205 John Raymond Murphy 31 Dec 2024

Schedules 13D/G Reported by John R. Murphy:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.